DONATE

The “Radical Science” programme comes to an end: an alliance between science, art and humanity

On 18 June, the CCCB hosted the closing ceremony of the programme, which offered an intense schedule of debates, artistic activities and meetings open to the public over the course of five months. These events aimed to explore how science will transform the world in the coming decades.

IBEC and GIPS lead a strategic conference connecting science and clinical practice to advance translational health research

Today marked the fourth annual conference of the Interdisciplinary Group of Health Professionals (GIPS), which featured the collaboration of the Institute for Bioengineering of Catalonia (IBEC) this year. The event welcomed over 150 attendees from clinical, academic, institutional, and technological backgrounds, and aimed to strengthen interdisciplinary collaboration and promote innovation in health.

IBEC co-organises Europe’s largest nanomedicine event to mark the 20th anniversary of NANOMED Spain and ETPN

The NanoMed Europe 2025 conference, Europe’s leading event in the field of nanomedicine and advanced health technologies, took place from 27 to 30 May. This edition was hosted in Barcelona, coinciding with the 20th anniversary of the Spanish Nanomedicine Platform (NANOMED Spain), which is coordinated by the Institute for Bioengineering of Catalonia (IBEC). Since its establishment in 2005, NANOMED Spain has collaborated closely with the European Technology Platform for Nanomedicine (ETPN) to encourage nanomedicine innovation in Spain and across Europe.

IBEC co-organised the leading international symposium on mutational scanning

Family foto of the 8th Mutational Scanning Symposium at the Barcelona Biomedical Research Park (PRBB).

More than 300 people attended the eighth Mutational Scanning Symposium, which took place from 21 to 23 May at the Barcelona Biomedical Research Park. The symposium is a key event for discussing the latest advances in mutational scanning technologies and Multiplex Assays of Variant Effects. This year, the symposium was co-organised by the Institute for Bioengineering of Catalonia, the Centre for Genomic Regulation, and the international Atlas of Variant Effects initiative.

IBEC and ICMS meet again in Eindhoven for their annual joint symposium

The joint ICMS-IBEC-MPIP symposium took place today, 24 March. The event was jointly organised by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Complex Molecular Systems (ICMS) and the Max Planck Institute for Polymer Research (MPIP). During the day, researchers from the three centres presented their areas of research, with the aim of strengthening the scientific relations between the institutions.

IBEC reinforces its leadership in biomedical innovation at Transfiere 2025

The Institute for Bioengineering of Catalonia took part last week in Transfiere, Europe’s largest R&D and knowledge transfer event. Representatives from the Institute were able to present the Complementary Plan for Biotechnology Applied to Health, the NANOMED Spain platform and the Biobanks and Biomodels Platform (PNBB), all projects coordinated by IBEC.

IBEC stands out at BIST Forum with 4 BIST Ignite projects and a BIST Ignite Award

Today, the BIST Forum, an event that brings together the BIST scientific community, focused this year on the joint initiative of the seven CERCA centres to promote precision medicine in healthy ageing. During the event, the new BIST Ignite projects to promote multidisciplinary research were announced, with IBEC involved in four of the five selected projects. In addition, one of the projects in which IBEC is involved won a BIST Ignite Award.

IBEC promotes dialogue on the translation of personalised medicine into society at Barcelona Health Innovation Week

Today, 19 February, IBEC organised the roundtable ‘Personalised medicine in action: from the lab to society’, an event that formed part of the Barcelona Health Innovation Week, promoted by Biocat. The session provided an insight into the keys to success in translating personalised medicine, connecting with actors in the innovation ecosystem and taking part in the conversation about the future of our health.